会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明公开
    • 퀴누클리딘 유도체의 신규한 염
    • 喹诺酮衍生物的新型盐
    • KR1020070110128A
    • 2007-11-15
    • KR1020077022738
    • 2006-03-06
    • 아스텔라스세이야쿠 가부시키가이샤
    • 하야까와,마사히꼬사미즈,기요히로우에바야시,히로시이께다,겐다께우찌,마꼬또
    • C07D453/02A61K31/4725A61P1/06A61P7/12
    • C07D453/02
    • An acid addition salt formed from (-)-(1R)-1-phenyl-1,2,3,4-tetrahydroisoquinoline-2-carboxylic acid (3R)-quinuclidin-3-yl ester and an acid selected from the group consisting of (-)-(2S,3S)-tartaric acid, (+)-(2S,3S)-di-o-benzoyltartaric acid, (+)-(2S,3S)-di-o-(4-methylbenzoyl) tartaric acid, (-)-L-phenylalanine, benzenesulfonic acid, cyclohexanesulfamic acid, hydrobromic acid, naphthalene-2-sulfonic acid, sebacic acid, (+)-camphor-10-sulfonic acid, p-toluenesulfonic acid, ethanesulfonic acid, methanesulfonic acid and methyl phosphate. This salt does not show hygroscopicity in such a level that is not desirable for use as a pharmaceutical agent or an active ingredient of a pharmaceutical agent, and therefore is an extremely useful compound for use as a pharmaceutical agent or an active ingredient of a pharmaceutical agent.
    • 由( - ) - (1R)-1-苯基-1,2,3,4-四氢异喹啉-2-羧酸(3R) - 奎宁环-3-基酯和选自以下的酸形成的酸加成盐: 的( - ) - (2S,3S) - 酒石酸,(+) - (2S,3S) - 二 - 邻 - 苯甲酰基酒石酸,(+) - (2S,3S) - 二 - (4-甲基苯甲酰基) 酒石酸,( - ) - L-苯丙氨酸,苯磺酸,环己烷氨基磺酸,氢溴酸,萘-2-磺酸,癸二酸,(+) - 樟脑-10-磺酸,对甲苯磺酸,乙磺酸,甲磺酸 酸和磷酸甲酯。 该盐在不能用作药剂或药剂的活性成分的水平不显示吸湿性,因此是用作药剂或药剂活性成分的极其有用的化合物 。
    • 2. 发明公开
    • 섬쑥부쟁이 추출물, 이의 분획물, 또는 이로부터 분리된 화합물을 함유하는 항경련용 조성물
    • 包含ASTER GLEHNI萃取物,其分离物或其分离的化合物的抗静电组合物
    • KR1020120067183A
    • 2012-06-25
    • KR1020100128642
    • 2010-12-15
    • 상지대학교산학협력단
    • 박희준
    • A61K36/28A61P1/06
    • A61K36/28A23L33/10A23V2002/00A23V2200/322
    • PURPOSE: An anticonvulsant composition containing Aster glehni extract, a fraction thereof, or compounds isolated from the same is provided to induce deep sleep and to suppress convulsion. CONSTITUTION: An anticonvulsant pharmaceutical composition contains Aster glehni extract, fraction thereof, or compounds isolated from the same as an active ingredient. The extract is prepared from Aster glehni leaves using water, low carbon number alcohols, or mixture solvent thereof. The fraction is an ethyl acetate fraction, hexane fraction, chloroform fraction, or butanol fraction. The dose of the composition is 250-500 mg/kg. An anticonvulsant food composition contains the extraction, fraction, or compounds. An anticonvulsant quasi-drug contains the extract, fraction, or compounds. The quasi-drug is used for manufacturing shower foam, detergent soap, hand wash, humidifier filler, mask, ointment or filter filler.
    • 目的:提供含有菊苣提取物,其一部分或从其分离的化合物的抗惊厥药组合物以诱导深度睡眠并抑制惊厥。 构成:抗惊厥药物组合物含有甲壳素提取物,其分数,或与其相同的活性成分分离的化合物。 使用水,低碳数醇或其混合溶剂,从翠菊叶制备提取物。 馏分为乙酸乙酯馏分,己烷馏分,氯仿馏分或丁醇馏分。 组合物的剂量为250-500mg / kg。 抗惊厥食品组合物含有提取物,级分或化合物。 抗惊厥药物含有提取物,级分或化合物。 准药用于制造淋浴泡沫,洗涤剂皂,手洗,加湿器填充剂,面膜,软膏或过滤填料。
    • 6. 发明公开
    • 창출의 새로운 추출방법
    • ATRIZYLODIS RHIZOMA的新提取方法
    • KR1020030080119A
    • 2003-10-11
    • KR1020020018148
    • 2002-04-03
    • 유종학
    • 유종학
    • A61K36/284A61P1/04A61P1/06
    • PURPOSE: Provided is a new extraction method of Atractylodis rhizoma which has pharmacological effect on stomach disorders including digestive disorders, stomachache, acute and chronic stomach inflammation, and the like. CONSTITUTION: A new method of Atractylodis rhizoma comprises the steps of: extracting Atractylodis rhizoma by heating at high temperature and under high pressure for a long time; maturing the extract for 24 hours; and vaporizing and the matured extract and concentrating it. The temperature, pressure and time for the extraction thereof are 100-110 deg. C, 2-2.5kg/cm¬2, and 15 hours, respectively.
    • 目的:提供了一种对胃溃疡具有药理作用的白术的新提取方法,包括消化系统疾病,胃痛,急性和慢性胃炎等。 构成:Atractylodis rhizoma的新方法包括以下步骤:通过在高温高压下长时间加热提取白术, 使提取物成熟24小时; 并蒸发成熟的提取物并浓缩。 其提取的温度,压力和时间为100-110度。 C,2-2.5kg / cm 2和15小时。
    • 10. 发明公开
    • 통증치료용 오가피
    • ACANTHOPANAX用于缓解疼痛
    • KR1020040060226A
    • 2004-07-06
    • KR1020020086768
    • 2002-12-30
    • 심인섭
    • 황혜정이배환함대현이혜정임사비나한승무심인섭
    • A61K36/254A61P1/00A61P1/06
    • PURPOSE: Provided is an Acanthopanax analgesic for relieving pain, which analgesic contains as an active ingredient Acanthopanax of which analgesic effect is verified by neuropathic pain model and formalin test. CONSTITUTION: An analgesic effect of Acanthopanax is characteristically verified by using neuropathic pain model and formalin test. Therefore, Acanthopanax analgesic contains main ingredients of Acanthopanax, such as Acanthoside A. B. C daucosterol, B-sitosterol, Sesamin, iriodendrin, Kaemferol-7-rhamnoside, Quercetin-7-rhamnoside, Hirsutin, taraxerol, 2-nonacodanone, hydrocarbon 1-dotria-contanol, scoparone, protocatechuic acid, ursolic acid, hyperine and 5-hydroxymethylfurfural and the like.
    • 目的:提供止痛止痛剂镇痛作为活性成分的刺五加止痛剂,通过神经性疼痛模型和福尔马林检验验证镇痛作用。 构成:使用神经性疼痛模型和福尔马林试验对刺五加的镇痛作用进行特征验证。 因此,刺五加镇痛剂含有刺五加的主要成分,例如Acanthoside AB C,蔗糖甾醇,β-谷甾醇,芝麻素,伊立替康,山奈酚7-鼠李糖苷,槲皮素-7-鼠李糖苷,海藻多糖,苦参酮,2-壬卡酮, 连翘醇,角叉菜酮,原儿茶酸,熊果酸,羟胺和5-羟甲基糠醛等。